Molecular Mechanism of the Role of Apigenin in the Treatment of Hyperlipidemia: A Network Pharmacology Approach
Chemistry & Biodiversity · 2023
DOI: 10.1002/cbdv.202200308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Shuhan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medicine, Chengde Medical University, Chengde, 067000, Hebei, P. R. China. Hauptthemen laut MEDLINE: Hyperlipidemias, Atherosclerosis, Drugs, Chinese Herbal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Education Department of Hebei Province, College Students Innovation and Entrepreneurship Training Project in Hebei Province, Special Project of Science and Technology Ability Cultivation for College and Middle School Students of Hebei Science and Technology Department.
Abstract (Originalsprache)
The therapeutic effect of apigenin (APG) on hyperlipidemia was investigated using network pharmacology combined with molecular docking strategy, and the potential targets of APG in the treatment of hyperlipidemia were explored. Genetic Ontology Biological Process (GOBP) and Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway enrichment analysis of common targets were performed. Then, molecular docking was used to predict the binding mode of APG to the target. Finally, Sprague Dawley rats were used to establish a hyperlipidemia model. The expression levels of insulin (INS) and vascular endothelial growth factor A (VEGFA) mRNA in each group were detected by quantitative reverse transcription‐polymerase chain reaction. Network pharmacological studies revealed that the role of APG in the treatment of hyperlipidemia was through the regulation of INS, VEGFA, tumor necrosis factor, epidermal growth factor receptor, matrix metalloprotein 9, and other targets, as well as through the regulation of the hypoxia‐inducible factor 1 (HIF‐1) signaling pathway, fluid shear stress, and atherosclerosis signaling pathways, vascular permeability; APG also participated in the regulation of glucose metabolism and lipid metabolism, and acted on vascular endothelial cells, and regulated vascular tone. Molecular docking showed that APG binds to the target with good efficiency. Experiments showed that after APG treatment, the expression levels of INS and VEGFA mRNA in the model group were significantly decreased ( p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Basic Medicine, Chengde Medical University, Chengde, 067000, Hebei, P. R. China.
- Department of Biochemistry, Chengde Medical University, Chengde, 067000, Hebei, P. R. China.
Förderung
- Education Department of Hebei Province
- College Students Innovation and Entrepreneurship Training Project in Hebei Province
- Special Project of Science and Technology Ability Cultivation for College and Middle School Students of Hebei Science and Technology Department
- Fundamental Research Funds for Chengde Medical University
- University-level scientific research project
Zitieren
APA
Li, S., Wang, Z., Zhou, Z., Gao, Z., Liu, Y., Li, J., Gao, X., Liu, J., Liu, H., & Xu, Q. (2023). Molecular Mechanism of the Role of Apigenin in the Treatment of Hyperlipidemia: A Network Pharmacology Approach. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202200308
Vancouver
Li S, Wang Z, Zhou Z, Gao Z, Liu Y, Li J, et al. Molecular Mechanism of the Role of Apigenin in the Treatment of Hyperlipidemia: A Network Pharmacology Approach. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202200308
BibTeX
@article{Li2023,
author = {Li, Shuhan and Wang, Zizhao and Zhou, Zhengnan and Gao, Zhiyuan and Liu, Yuai and Li, Jie and Gao, Xingbang and Liu, Jing and Liu, Hanbing and Xu, Qian},
title = {Molecular Mechanism of the Role of Apigenin in the Treatment of Hyperlipidemia: A Network Pharmacology Approach},
journal = {Chemistry & Biodiversity},
year = {2023},
doi = {10.1002/cbdv.202200308}
}
EUVIMED